Subscribe: Market Wire - Medical and Healthcare: Healthcare
Added By: Feedage Forager Feedage Grade A rated
Language: English
announces  company  epic  health  healthcare  jan  marketwired jan  marketwired january  marketwired  ontario marketwired  otcqb  shares 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Healthcare

Marketwired - Healthcare

Marketwired - Healthcare

Last Build Date: Fri, 19 Jan 2018 13:37:47 EST

Copyright: Copyright: (C) Marketwired

NanoVibronix CEO Brian Murphy Appears on Varney & Co. on Fox Business; Comments on Role of PainShield in Fighting Opioid Epidemic

Fri, 19 Jan 2018 13:06:22 EST

ELMSFORD, NY--(Marketwired - January 19, 2018) - NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, CEO of NanoVibronix, appeared as a guest on Varney & Co on Fox Business this morning to discuss the benefits of PainShield and its potential role in helping individuals suffering from chronic pain reduce their dependence on opioids

Nova Leap Health Corp. Announces Brokered Private Placement with Haywood Securities Inc.

Fri, 19 Jan 2018 08:44:28 EST

HALIFAX, NOVA SCOTIA--(Marketwired - Jan. 19, 2018) -

Virgin Pulse Acquires Preventure

Thu, 18 Jan 2018 17:00:00 EST

Company continues on aggressive growth trajectory in 2018; Extends leadership as largest global provider of SaaS-based employee health and wellbeing solutions

Rennova Health's Epic Reference Labs Receives Accreditation From College of American Pathologists

Wed, 17 Jan 2018 09:20:00 EST

WEST PALM BEACH, FL--(Marketwired - January 17, 2018) - Rennova Health, Inc. (OTCQB: RNVA), (OTCQB: RNVAW) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, that opened its first rural hospital in Oneida, Tenn. in August 2017, announces that its flagship Laboratory, EPIC Reference Labs, Inc. (EPIC) has successfully met the Laboratory Accreditation Program Standards for Accreditation from the College of American Pathologists (CAP). EPIC has been operating as a urine toxicology testing laboratory in Riviera Beach, Fla. since 2015.

Scythian Biosciences Corp. Announces Increase to Bought Deal Financing With Serruya Private Equity and the Delavaco Group as Other Strategic Investors

Wed, 17 Jan 2018 09:16:48 EST

TORONTO, ONTARIO--(Marketwired - Jan. 17, 2018) -

Intrinsic4D Announces Shares for Debt Transactions and Convertible Loan Agreement

Tue, 16 Jan 2018 11:07:12 EST

TORONTO, ONTARIO--(Marketwired - Jan. 16, 2018) - Intrinsic4D Inc. (the "Company") (NEX:IFD.H) announces that it has entered into shares for debt agreements with 65 arm's length creditors, pursuant to which the Company will issue an aggregate of 67,228,184 common shares at a deemed price of $0.05 per share in satisfaction of indebtedness currently owed pursuant to convertible debentures issued by the Company on March 17, 2016, May 17, 2016 and June 1, 2016 for aggregate principal amount of $3,133,000. The common shares issued in satisfaction of the indebtedness will be subject to a four month and one day hold period from the date of issuance.

Avalon GloboCare Appoints Dr. Bo Chen as Vice President of Mergers & Acquisitions to Accelerate Growth

Tue, 16 Jan 2018 08:00:00 EST

FREEHOLD, NJ--(Marketwired - January 16, 2018) - Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that the Company has appointed Dr. Bo Chen as Vice President, Business Development to lead mergers & acquisitions activity. Dr. Chen will focus on executing Avalon's acquisition strategy by helping identify companies with a strategic fit within the cell therapeutics, cell diagnostics and rehabilitation sectors.

Tetra Bio-Pharma Receives Approval from Health Canada of its Phase 1 Clinical Trial with PPP005 (Cannabis Oil)

Tue, 16 Jan 2018 08:00:00 EST

OTTAWA, ONTARIO--(Marketwired - Jan. 16, 2018) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce that it has received a No Objection Letter (NOL) from the Therapeutic Products Directorate (TPD), Health Canada to evaluate the safety, pharmacokinetics and pharmacodynamics of its cannabis oil PPP005.

CTD Holdings' European Clinical Trial Adopted by National Institute for Health Research of England

Tue, 16 Jan 2018 08:00:00 EST

Collaboration Will Provide Infrastructure Support to Study

Imagin Medical Recruits Senior Healthcare Industry CFO

Mon, 15 Jan 2018 16:07:03 EST

VANCOUVER, BC and BOSTON, MA--(Marketwired - January 15, 2018) - Imagin Medical (CSE: IME) (CSE: IME.CN) (CNSX: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (STUT: DPD2) (the "Company") announced today that it hired John Vacha as the Company's new CFO.

Prevtec Microbia reçoit une autorisation de mise en marché du Coliprotec® F4 de la part du USDA

Mon, 15 Jan 2018 10:15:28 EST

Un financement d'un important fonds d'investissement canadien jusqu'à hauteur de CAD$10 millions est obtenu

Prevtec Microbia Receives Market Authorization from USDA for Coliprotec® F4

Mon, 15 Jan 2018 10:14:18 EST

Up to CAD$10 million in Financing Secured from a Large Canadian Investment Fund